Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
27.5M
-
Shares change
-
+1.29M
-
Total reported value, excl. options
-
$257M
-
Value change
-
+$10M
-
Number of buys
-
52
-
Number of sells
-
-34
-
Price
-
$9.37
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q2 2019
105 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q2 2019.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.5M shares
of 37.4M outstanding shares and own 73.36% of the company stock.
Largest 10 shareholders include NWQ INVESTMENT MANAGEMENT COMPANY, LLC (3.42M shares), WYNNEFIELD CAPITAL INC (2.8M shares), DIMENSIONAL FUND ADVISORS LP (2.41M shares), BlackRock Inc. (1.88M shares), VANGUARD GROUP INC (1.81M shares), Russell Investments Group, Ltd. (1.79M shares), FRANKLIN RESOURCES INC (1.52M shares), Walthausen & Co., LLC (1.16M shares), HEARTLAND ADVISORS INC (1.04M shares), and Boston Partners (904K shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.